Nasdaq · Healthcare
MANNATECH INC (MTEX)
As-reported financials and recent SEC filings for MANNATECH INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$108.0M
Net income
$-15.2M
Net margin
-14.1%
Diluted EPS
$-8.00
ROE
291.3%
P/E (TTM)
—
Market cap
—
Debt / equity
-0.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $108.0M | $117.9M | $132.0M | $137.2M | $159.8M |
| Gross profit | $81.0M | $91.5M | $102.9M | $104.1M | $125.6M |
| Operating income | $-426,000 | $1.4M | $-964,000 | $-405,000 | $9.0M |
| Net income | $-15.2M | $2.5M | $-2.2M | $-4.5M | $9.8M |
| Diluted EPS | $-8.00 | $1.32 | $-1.20 | $-2.35 | $4.71 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-18
View on EDGAR →32026-06-18
View on EDGAR →8-K2026-06-08
View on EDGAR →42026-06-05
View on EDGAR →42026-06-05
View on EDGAR →8-K2026-06-03
View on EDGAR →42026-05-21
View on EDGAR →42026-05-20
View on EDGAR →Largest Healthcare peers
Go deeper on MTEX
Search MANNATECH INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.